Komori
General Meetings of Shareholders219AHeartseed Inc.Pharmaceuticals

Notice of Convocation of the 10th Annual General Meeting of Shareholders

For the 10th Annual General Meeting of Shareholders, the company will submit proposals concerning amendments to the Articles of Incorporation, the election of 7 directors and the introduction of a stock-based compensation plan for directors other than outside and part-time directors. The number of directors will decrease from the current 8 to 7, all 7 will be candidates for reappointment, and there will be 2 outside directors.

Worth reading
57In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
150000
株／年（株式報酬制度の交付株式数上限）
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (10th)
2026年
3月27日
Date and time（金曜日）午前10時00分（受付開始：午前9時30分）21 days from this disclosure to the meeting
Matters for resolution3 items

  1. Partial Amendment to the Articles of Incorporation

  2. Election of 7 Directors

  3. 取締役（社外取締役及び非常勤取締役を除く）に対する事後交付型株式報酬（リストリクテッド・ストック・ユニット）制度導入の件

Shareholder Proposal

None (not specified)

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Director nominee
7Nominees
0New
2Outside
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (10th)
Date and time2026年3月27日（金曜日）午前10時00分（受付開始：午前9時30分）
Matters for resolutionProposal No. 1: Partial Amendment to the Articles of Incorporation, Proposal No. 2: Election of 7 Directors, 第３号議案 取締役（社外取締役及び非常勤取締役を除く）に対する事後交付型株式報酬（リストリクテッド・ストック・ユニット）制度導入の件
Shareholder ProposalNone (not specified)
Director nominee7, including 0 new candidates and 2 outside directors
Items this document does not state (1)
Percentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

取締役の任期短縮は経営責任を明確にし、経営環境の変化に迅速に対応できる体制と株主の信任機会を整えるため。剰余金の配当等を取締役会決議で行えるようにする変更は、将来の機動的な資本政策・配当政策を可能にするため。取締役7名体制への移行は、意思決定・監督機能に重点を置き、執行役員制度の導入によって業務執行体制を充実させるため。株式報酬制度は、中長期的な企業価値向上のインセンティブ付与と株主との価値共有を進めるため。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Convocation of the 10th Annual General Meeting of Shareholders | Heartseed Inc. (219A) timely disclosure | Komori